/>

Wednesday, January 30, 2019

NEWS 30 JAN 2019

NEWS FROM USA

New Paragraph IV filing

DRUG

Dosage form

Corresponding RLD

Date of Submission

Type of Submission (Based on Date)

Ibrutinib

(140 And 560 Mg)

Tablets

Imbruvica

05 Nov 2018

Post NCE-1 Submission For New Dosage Form

Ibrutinib

(280 And 420 Mg)

Tablets

Imbruvica 

14 Dec 2018

Post NCE-1 Submission For New Dosage Form

 

NDA Approvals                    

Approval Date

Drug

NDA Sponsor

Brand Name

Prescribing information

28 Jan 2019

Sumatriptan Nasal Spray

Dr Reddys

Tosymra

Link

 

ANDA Approvals                                                  

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

25 Jan 2019

Diphenhydramine Hydrochloride; Naproxen Sodium Tablets

Actavis 

Aleve Pm (Bayer)

One (Amneal)

25 Jan 2019

Eptifibatide Injection

Hainan Poly 

Integrilin (Schering)

Eight

25 Jan 2019

Dicyclomine Hydrochloride Injection

Fresenius 

Bentyl (Allergan)

Six

25 Jan 2019

Fluoxetine Hydrochloride Tablets

Dr Reddys 

Fluoxetine Hydrochloride (Alvogen)

Five

25 Jan 2019

Tizanidine Hydrochloride Tablets

Alkem 

Zanaflex (Covis)

Eleven

25 Jan 2019

Mesalamine DR Tablets

Sun Pharma

Lialda (Shire)

Three

28 Jan 2019

Calcium Chloride; Potassium Chloride; Sodium Chloride; Sodium Lactate Injection

Fresenius 

Lactated Ringer's In Plastic Container (Baxter)

Two (B Braun, Icu Medical)

28 Jan 2019

Clindamycin Phosphate Topical Solution

Encube 

Cleocin T (Pharmacia And Upjohn)

Ten

28 Jan 2019

Medroxyprogesterone Injectable

Cipla

Depo-Provera (Pfizer)

Five

28 Jan 2019

Desmopressin Acetate  Tablets

Abhai 

Ddavp (Ferring)

Six

28 Jan 2019

Bupropion Hydrochloride ER Tablets

Graviti 

Wellbutrin Xl (Valeant)

Seventeen

28 Jan 2019

Tazarotene Cream

(1%)

Fougera 

N/A

None

 

Tentative ANDA Approvals 

Approval Date

Drug

Company

22 Jan 2019

Topiramate

Glenmark 

25 Jan 2019

Bendamustine Hydrochloride

Celerity Pharms

25 Jan 2019

Dextroamphetamine Saccharate

Sun Pharma

28 Jan 2019

Fosaprepitant Dimeglumine

MSN Labs 

28 Jan 2019

Eslicarbazepine Acetate

Alkem Labs 

29 Jan 2019

Pregabalin

Alkem Labs 

 

 

 

 

 

 

 

 

 

 

USFDA Inspections 

Dishman gets EIR for its Bavla plant

 

If you have any query/suggestion then please write us at pharmacaption@gmail.com

Monday, January 28, 2019

NEWS 28 JAN 2019

NEWS FROM USA

ANDA Approvals                                                  

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

23 Jan 2019

Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride Solution

Torrent

Rezira (Cypress)

Two (Mayne, Paddock)

23 Jan 2019

Ticagrelor Tablets

Amneal 

Brilinta (Astrazeneca)

Two (Hisun Pharm, Watson )

23 Jan 2019

Ticagrelor Tablets

Hisun Pharm Hangzhou

Brilinta (Astrazeneca)

Two (Amneal, Watson )

23 Jan 2019

Clobetasol Propionate Ointment

Teligent 

N/A

Ten

24 Jan 2019

Dorzolamide Hydrochloride Ophthalmic Drops

FDC Ltd

Trusopt (Merck)

Five

24 Jan 2019

Buprenorphine Hydrochloride; Naloxone Hydrochloride Sublingual

Alvogen Pine 

Suboxone (Indivior)

Two (Dr Reddys, Mylan)

28 Jan 2019

Medroxyprogesterone Injectable

Cipla

Depo-Provera (Pfizer)

Five

 

Tentative ANDA Approvals 

Approval Date

Drug

Company

22 Jan 2019

Topiramate XR capsules

Glenmark 

 

 

 

USFDA Inspections 

USDFA concludes audit at Indoco’s Goa Plant I

U.S. FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility

 

If you have any query/suggestion then please write us at pharmacaption@gmail.com

Thursday, January 24, 2019

NEWS 24 JAN 2019

NEWS FROM USA

New Paragraph IV filing

DRUG

Dosage form

Corresponding RLD

Date of Submission

Type of Submission (Based on Date)

Ibrutinib

(70 mg)

Capsules

Imbruvica

14 Dec. 2018

Post NCE-1 submission for new strength

 

NEW GENERICS LAUNCHES IN THE US

 DRUG

COMPANY

Corresponding RLD

Annual sales quoted in press release as per IQVIA

Press Release

Propofol injectable emulsion

Dr. Reddy’s laboratories

Diprivan

$ 310 millions

Link

 

ANDA Approvals                                                  

Approval Date

Drug Product

ANDA

Sponsor

Corresponding RLD

Number Of Other Approved Generics

18 Jan 2019

Imatinib Mesylate

Wockhardt

Gleevec (Novartis)

Seven

17 Jan 2019

Imatinib Mesylate

Shilpa Medicare

Gleevec (Novartis)

Seven

18 Jan 2019

Levothyroxine Tablets

Lupin

Synthroid

(Abbvie)

Four

18 Jan 2019

Dexmedetomidine Hydrochloride Injection

Cipla

Precedex (Hospira)

Fourteen

18 Jan 2019

Lansoprazole DR Oral Capsule

Alkem Labs 

Prevacid (Takeda)

Fourteen

18 Jan 2019

Cyclophosphamide Capsules

Cipla

Cyclophosphamide (West-Ward)

Two (Amerigen, Sti Pharma)

18 Jan 2019

Acyclovir Ointment

Cipla

Zovirax (Valeant)

Nine

22 Jan 2019

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate ER Capsules

Amerigen 

Adderall Xr (Shire)

Four

22 Jan 2019

Potassium Chloride ER Tablets

Pii

Klor-Con (Upsher Smith)

Seven

22 Jan 2019

Dofetilide Capsules

Aurobindo 

Tikosyn (Pfizer)

Five

22 Jan 2019

Tretinoin Cream

Taro 

Retin-A (Valeant Pharms)

One (Perrigo)

           

Tentative ANDA Approvals 

Approval Date

Drug

Company

18 Jan 2019

Esomeprazole Magnesium

Zydus Pharms 

18 Jan 2019

Carfilzomib

Apotex

18 Jan 2019

Carfilzomib

Qilu Pharma

18 Jan 2019

Dapagliflozin

Hetero Labs

22 Jan 2019

Abiraterone Acetate

Glenmark 

 

 

 

 

 

 

 

 

 

 

 

NEWS RELATED TO GENERIC PATENT LITIGATION

Palonosetron (Helsinn v. Teva): US Supreme court rules in favour of Teva in Palonosetron on-sale bar case.

 

If you have any query/suggestion then please write us at pharmacaption@gmail.com